Vimarsana
Biggest News Aggregation in the World

Page 9 - Poster Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Section Today - Breaking & Trending Today

Demonstration of Accurate Screening of Gene Dependency in Multiple Myeloma from Aitia's Gemini Digital Twins to be Presented at 2023 AACR Annual Meeting - Vimarsana News

Demonstration of Accurate Screening of Gene Dependency in Multiple Myeloma from Aitia's Gemini Digital Twins to be Presented at 2023 AACR Annual Meeting

/PRNewswire/ -- Aitia, the leader in the application of causal AI and "Digital Twins" to discover and develop new drugs, announced today that data from its...

UPDATE -- Actuate Therapeutics Announces Poster - Vimarsana News

UPDATE -- Actuate Therapeutics Announces Poster

CHICAGO and FORT WORTH, Texas, April 10, 2023 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company,...

Acepodia to Present Preclinical Data of Gamma Delta T cell Therapy Candidate, ACE2016, an off-the-shelf EGFR-targeting γδ2 T cell therapy against EGFR-expressing solid tumors - Vimarsana News

Acepodia to Present Preclinical Data of Gamma Delta T cell Therapy Candidate, ACE2016, an off-the-shelf EGFR-targeting γδ2 T cell therapy against EGFR-expressing solid tumors

/PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique antibody-cell conjugation (ACC)...

Antengene Announces Five Upcoming Presentations at the 2023 American Association for Cancer Research Annual Meeting - Vimarsana News

Antengene Announces Five Upcoming Presentations at the 2023 American Association for Cancer Research Annual Meeting

/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering,...

Celcuity Inc.: Celcuity to Present Preclinical Data on Therapeutic Effects of Gedatolisib in Gynecological Cancer Models at AACR Annual Meeting 2023 - Vimarsana News

Celcuity Inc.: Celcuity to Present Preclinical Data on Therapeutic Effects of Gedatolisib in Gynecological Cancer Models at AACR Annual Meeting 2023

MINNEAPOLIS, MN / ACCESSWIRE / March 15, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced publication